ACP-196 Versus Placebo in Subjects With Rheumatoid Arthritis on Background Methotrexate

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

June 30, 2016

Conditions
Rheumatoid Arthritis
Interventions
DRUG

acalabrutinib

DRUG

Placebo

Trial Locations (17)

16635

Altoona Center for Clinical Research, Duncansville

28144

PMG Research of Salisbury, Salisbury

33015

San Marcus Research Clinic, Inc., Hialeah

34652

Suncoast Clinical Research, Inc., New Port Richey

Suncoast Clinical Research, New Port Richey

35216

Achieve Clinical Research, Birmingham

36207

Pinnacle Research Group, Anniston

38119

Ramesh C. Gupta, MD, Memphis

77598

Clear Lake Regional Medical Center, Webster

85258

Advanced Arthritis Care and Research, Scottsdale

89128

Office of George Timothy Kelly, MD, Las Vegas

91786

Inland Rheumatology and Osteoporosis Medical Group, Inc, Upland

92020

TriWest Research Associates, LLC, El Cajon

92868

Neuropsychiatric Research Center of Orange County, Orange

93454

Pacific Arthritis Center Medical Group, Santa Monica

34684-3176

The Arthritis Center, Palm Harbor

73103-2433

Health Research of Oklahoma, Oklahoma City

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Acerta Pharma BV

INDUSTRY